$RNN Roth Capital Maintained Buy On Rexahn Pharmaceuticals On FDA Orphan Designation http://www.smarteranalyst.com/2014/09/25/roth-capital-maintained-buy-rexahn-pharmaceuticals-fda-orphan-designation/